GSK Pricing Information for TRELEGY Ellipta

Find pricing information and learn more about the list price of TRELEGY.

TRELEGY logo

What is the list price of TRELEGY?

  • The list price for a 30-day supply of TRELEGY is $657.681, but it's important to remember the list price is not the price you pay.
  • If you have health insurance, the price you pay – sometimes called your out-of-pocket cost – is set by your prescription drug plan.
  • To better understand your out-of-pocket cost, contact your insurance provider because they know the details of your plan.

What can I expect to pay for TRELEGY?

    What does list price mean to me?

    • The list price does not represent the actual price you will pay for a medicine.
    • The link between list price and what you pay can be confusing. With medicines, a lower list price is no guarantee of a lower out-of-pocket cost.
    • If you have prescription drug coverage, your insurance company is the best resource to understand your out-of-pocket cost.
    • if you do not have prescription drug insurance or if your medicine is not covered by your insurance, talk to a pharmacist where you purchase your medicine to better understand your cost.

    Where can I get more information?

    • To learn more about TRELEGY, visit Trelegy.com.
    • For more accurate information about your out-of-pocket cost, contact your insurance provider as they know the details of your plan.
    • To talk to a GSK representative, call 1-866-398-0020.
      Hours: Monday through Friday, 8:30 am to 5:30 pm ET.
    Computer icon

    Want to learn more about TRELEGY?

    Reference

    1. Source: GSK Data on File as of January 1, 2024.
    2. IQVIA LAAD Rx, IQVIA US Market Access Analytic Solutions analysis. Accessed on October 25, 2024. Based on analysis of national pharmacy level data of commercially and Medicare insured patients who filled their prescription at the pharmacy between October 2023 - September 2024. The analysis includes only claims that were paid, or for which price was accepted by patients after using insurance and/or any copay cards, discount cards or other offers, and for which data about the transaction was available. The analysis consisted of fill data for TRELEGY ELLIPTA (fluticasone furoate, umeclidinium and vilanterol inhalation powder).
    3. Centers for Medicare & Medicaid Services (CMS). Medicaid and CHIP Overview for Assisters. Version 3.0. September 2024. https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf Accessed on October 25, 2025.
       
    Two men and two women clasping hands

    Find a GSK program for you

    Answer a few quick questions.

    Young adults in wetsuits with surfboards

    Have private insurance?

    See access and copay assistance programs for certain products.

    Middle-aged woman holding flowerpots

    Are you uninsured or have Medicare?

    Get help paying for certain products.

    GSK Help Center logo

    Explore the GSK Help Center website to find customer service support and contact information.